Accelerate to discover
Related topics
Improved differentiation of Retinal Organoids stem cells derived using rotating-wall vessels
Jan 15, 2019
Pluripotent stem cells can be differentiated into 3D retinal organoids, with major cell types self-patterning into a...
IncuCyte webinar recording: CAR T-cell therapy, frontiers in cancer Immunotherapy
Jan 11, 2019
The success of immune checkpoint blockade adds new therapeutic category to Cancers are the most heterogenous group of...
CT‐analyzer plug‐ins: ROI shrink‐wrap and primitive ROI
Jan 7, 2019
The ROI shrink‐wrap gives the possibility to automatically generate a region‐of‐interest by adapting to the shape of...
ACEA Biosciences launch xCELLigence RTCA software Pro for immunotherapy applications
Dec 28, 2018
RTCA Software Pro is an integrated software package for running and analyzing real time cell analysis data from...
Cellular stress induces erythrocyte assembly and promotes microangiopathy
Dec 19, 2018
Microangiopathy with subsequent organ damage represents a major complication in several diseases. The mechanisms...
The need for ultra high field magnetic resonance imaging
Dec 17, 2018
MRI is a noninvasive imaging technology that is known for its superior soft tissue contrast and ability to provide...
Live-cell labeling of endogenous proteins with nanometer precision by transduced nanobodies
Dec 6, 2018
Accurate labeling of endogenous proteins for advanced light microscopy in living cells remains challenging. Nanobodies...
Bioflux webinar: Blockade of CD62L inhibits CLL cell interaction with vascular endothelium
Nov 22, 2018
CD62L (L-selectin) is a key adhesion molecule that promotes cell tethering and rolling along the vascular endothelium...
Mar 22, 2016
The mutations driving cancer create clonal populations that differ not just between cancer patients, but within individual tumors. These mutations contain small but significant populations which may survive treatment and metastasize. The only method to get a complete picture of tumor clonality is by sequencing single cells.
In this webinar, you will learn how you can make breakthrough discoveries in your research using single-cell DNA Sequencing. Dr. Ioannis Ragoussis of McGill University will share his research using single-cell whole exome sequencing to reveal the true heterogeneity and cell lineages present in triple negative breast cancer.
Brand profile
Fluidigm is a Molecular and Single Cell Biology company that creates microfluidic-based chips and instrumentation for Life-Science research.
More info at:
www.fluidigm.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
